Cookie Policy

We've put some small files called essential cookies on your device to help our site work on your browser.
We also use analytical cookies to help up improve our website by collecting and reporting information on it's usage.

You can read more above this on our Privacy Policy page.

I'm ok with analytical cookies Do not use analytics cookies


Our achievements would not be possible without the outstanding team that make up Shield Therapeutics’ staff, management and board of directors.

Chief Financial Officer

Hans-Peter Rudolf

Hans-Peter is Chief Financial Officer at Shield and brings extensive international experience to the senior team. Hans-Peter studied at the University of Zurich and Cleveland State University, Ohio,  Hans-Peter is a US Certified Public Accountant (CPA).  Hans-Peter began his career in 1991 in public practice with Deloitte in Cleveland, Ohio, before joining Ernst & Young (Switzerland) where he became a partner in 2001 and moved back to the Cleveland office in 2003 as an audit partner. In 2006 he joined Crowe Horwath (now Crowe) as an audit partner within the 8th largest global accounting network. In 2011 Hans-Peter left public practice to become Head of Group Accounting at COFRA Group, a privately held Swiss conglomerate with activities in retail, real estate and investment, employing over 50,000 people worldwide. In 2017, he was appointed as Chief Financial Officer at Vicarius Pharma, a start-up company offering research-driven pharma and biotech companies a platform to build a dedicated European commercial organisation to market and sell their assets through long-term license and partnership agreements.

Back to team